Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

NASDAQ:CBAT - Nasdaq - US14986C1027 - Common Stock - Currency: USD

1.11  -0.02 (-1.77%)

After market: 1.12 +0.01 (+0.9%)

Fundamental Rating

4

Overall CBAT gets a fundamental rating of 4 out of 10. We evaluated CBAT against 93 industry peers in the Electrical Equipment industry. There are concerns on the financial health of CBAT while its profitability can be described as average. CBAT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CBAT has reported negative net income.
CBAT had a positive operating cash flow in the past year.
In multiple years CBAT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: CBAT reported negative operating cash flow in multiple years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

CBAT has a better Return On Assets (0.12%) than 67.74% of its industry peers.
CBAT has a Return On Equity of 0.31%. This is in the better half of the industry: CBAT outperforms 67.74% of its industry peers.
CBAT has a Return On Invested Capital of 0.86%. This is in the better half of the industry: CBAT outperforms 63.44% of its industry peers.
Industry RankSector Rank
ROA 0.12%
ROE 0.31%
ROIC 0.86%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

Looking at the Profit Margin, with a value of 0.25%, CBAT is in the better half of the industry, outperforming 67.74% of the companies in the same industry.
CBAT's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 1.09%, CBAT is doing good in the industry, outperforming 63.44% of the companies in the same industry.
With a Gross Margin value of 21.68%, CBAT perfoms like the industry average, outperforming 49.46% of the companies in the same industry.
In the last couple of years the Gross Margin of CBAT has grown nicely.
Industry RankSector Rank
OM 1.09%
PM (TTM) 0.25%
GM 21.68%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

3

2. Health

2.1 Basic Checks

CBAT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CBAT remains at a similar level compared to 1 year ago.
CBAT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBAT has an improved debt to assets ratio.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of 0.15, we must say that CBAT is in the distress zone and has some risk of bankruptcy.
CBAT's Altman-Z score of 0.15 is in line compared to the rest of the industry. CBAT outperforms 48.39% of its industry peers.
CBAT has a debt to FCF ratio of 51.08. This is a negative value and a sign of low solvency as CBAT would need 51.08 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 51.08, CBAT is in the better half of the industry, outperforming 63.44% of the companies in the same industry.
A Debt/Equity ratio of 0.28 indicates that CBAT is not too dependend on debt financing.
CBAT has a Debt to Equity ratio (0.28) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 51.08
Altman-Z 0.15
ROIC/WACC0.14
WACC6.05%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 0.82 indicates that CBAT may have some problems paying its short term obligations.
The Current ratio of CBAT (0.82) is worse than 81.72% of its industry peers.
CBAT has a Quick Ratio of 0.82. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
CBAT has a Quick ratio of 0.64. This is in the lower half of the industry: CBAT underperforms 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.64
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

5

3. Growth

3.1 Past

CBAT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.00%.
The earnings per share for CBAT have been decreasing by -42.83% on average. This is quite bad
The Revenue for CBAT has decreased by -30.85% in the past year. This is quite bad
Measured over the past years, CBAT shows a very strong growth in Revenue. The Revenue has been growing by 51.40% on average per year.
EPS 1Y (TTM)-100%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-118.18%
Revenue 1Y (TTM)-30.85%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-40.6%

3.2 Future

CBAT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -20.77% yearly.
Based on estimates for the next years, CBAT will show a quite strong growth in Revenue. The Revenue will grow by 11.79% on average per year.
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-30.04%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.1 -0.1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Forward Earnings ratio of 13.60, CBAT is valued correctly.
CBAT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CBAT is cheaper than 88.17% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CBAT to the average of the S&P500 Index (36.44), we can say CBAT is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 13.6
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CBAT is valued cheaper than 94.62% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CBAT is valued a bit cheaper than the industry average as 63.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 151.01
EV/EBITDA 8.23
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

A cheap valuation may be justified as CBAT's earnings are expected to decrease with -20.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-20.77%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBAT!.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (7/18/2025, 8:00:02 PM)

After market: 1.12 +0.01 (+0.9%)

1.11

-0.02 (-1.77%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)05-19 2025-05-19/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners2.08%
Inst Owner Change0%
Ins Owners25.43%
Ins Owner Change0%
Market Cap99.83M
Analysts0
Price Target1.53 (37.84%)
Short Float %1.27%
Short Ratio3.6
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-42.35%
Min Revenue beat(2)-50.36%
Max Revenue beat(2)-34.33%
Revenue beat(4)0
Avg Revenue beat(4)-33.59%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)-24.56%
Revenue beat(8)1
Avg Revenue beat(8)-19.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-400%
EPS NY rev (3m)-209.09%
Revenue NQ rev (1m)-31.52%
Revenue NQ rev (3m)-31.52%
Revenue NY rev (1m)-36.83%
Revenue NY rev (3m)-36.83%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.6
P/S 0.65
P/FCF 151.01
P/OCF 4.41
P/B 0.83
P/tB 0.83
EV/EBITDA 8.23
EPS(TTM)0
EYN/A
EPS(NY)0.08
Fwd EY7.35%
FCF(TTM)0.01
FCFY0.66%
OCF(TTM)0.25
OCFY22.67%
SpS1.7
BVpS1.34
TBVpS1.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.12%
ROE 0.31%
ROCE 1.22%
ROIC 0.86%
ROICexc 0.91%
ROICexgc 0.92%
OM 1.09%
PM (TTM) 0.25%
GM 21.68%
FCFM 0.43%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 51.08
Debt/EBITDA 3.07
Cap/Depr 234.88%
Cap/Sales 14.39%
Interest Coverage 3.34
Cash Conversion 205.51%
Profit Quality 176.53%
Current Ratio 0.82
Quick Ratio 0.64
Altman-Z 0.15
F-Score3
WACC6.05%
ROIC/WACC0.14
Cap/Depr(3y)228.34%
Cap/Depr(5y)286.62%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-118.18%
EPS Next Y-194.15%
EPS Next 2Y-20.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.85%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-40.6%
Revenue Next Year-30.04%
Revenue Next 2Y11.79%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-90.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.61%
OCF growth 3YN/A
OCF growth 5YN/A